NewsAI-assisted

Amylyx Pharmaceuticals To Attend Evercore ISI HealthCONx Conference

Amylyx will host a fireside chat at the Evercore ISI HealthCONx Conference on Dec 4. Live stream and replay are available on the company site.

By Simantini Singh Deo

Senior Content Writer

Nov 28, 2024Updated Jun 26, 2025 · 2 min read

Amylyx Pharmaceuticals To Attend Evercore ISI HealthCONx Conference — https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20210414005066%2Fen%2FAmylyx-Pharmaceuticals-Provides-Global-Regulatory-Update-on-AMX0035-for-ALS&psig=AOvVaw3QOEGq2FJxt0i7CDeXYLrh&ust=1732876177994000&source=images&cd=vfe&opi=89978449&ved=0CAMQjB1qFwoTCJCou_ro_okDFQAAAAAdAAAAABAR

AI-assisted reporting

Reviewed by Simantini Singh Deo, Senior Content Writer

Amylyx Pharmaceuticals, Inc. has announced that its management team will attend the 7th Annual Evercore ISI HealthCONx Conference. The conference will be held in person in Coral Gables, Florida, with a fireside chat scheduled for Wednesday, December 4, 2024, at 11:15 a.m. ET.

The event will be available for live streaming via the "Events and Presentations" section under the Investor page of the company’s website. The recording will be accessible for 90 days post-event.

TopicsNews

Written by

Simantini Singh Deo

Senior Content Writer

Simantini Singh Deo works on the latest and trending news happening daily in the pharma world.

Discussion

Loading discussion…

Amylyx Pharmaceuticals To Attend Evercore ISI HealthCONx Conference

Discussion

More from Pharma News

Bristol-Myers Squibb Gains FDA Accelerated Approval for Iberdomide in Relapsed or Refractory Multiple Myeloma

Eton Pharmaceuticals Gains FDA Fast Track for AMGLIDIA and Targets 2027 NDA with ASN-001 Acquisition

Eledon Pharmaceuticals Gains FDA End-of-Phase 2 Alignment for Tegoprubart Ahead of Global Phase 3 Kidney Trial